FMC Corp to Acquire BioPhero ApS - M&A Call Transcript
Hello, and welcome to today's BioPhero acquisition conference call. My name is Elliot, and I will be coordinating your call today. (Operator Instructions) I would now like to turn the call over to Zack Zaki, Director of Investor Relations. The floor is yours. Please go ahead.
Good morning, everyone, and thank you for participating in today's call to discuss FMC Corporation's agreement to acquire BioPhero. Joining me today are Mark Douglas, President and Chief Executive Officer; Andrew Sandifer, Executive Vice President and Chief Financial Officer; and Dr. Kathleen Shelton, Executive Vice President and Chief Technology Officer.
Mark will begin with highlights of the acquisition, introduce the current pheromone market and provide a view of the sizable market potential for BioPhero's unique technology. Following the prepared remarks, we will take questions. Yesterday's press release and today's slide presentation is available on our website, and the prepared remarks from today's discussion will be made available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |